
Overview
I study and provide care for children and adults with primary immune defects, such as those with severe combined immune deficiency disease, humoral immune defects, and those with phagocytic cell deficiency diseases. I am the primary investigator on NIH funded projects that address the immune dysregulation present in patients with persistent viral infection, specifically chronic human papillomavirus infection, that prevents control or eradication of recurrent HPV infection in patients with recurrent respiratory papillomatosis.
Dr. Bonagura is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Primary Immunodeficiency (PID), Immunodeficiency with Hyper IgM Type 1, DiGeorge Syndrome, and Selective Deficiency of IgA.
Dr. Bonagura is board certified in American Board Of Pediatrics and American Board Of Allergy & Immunology. He is actively involved in clinical research, co-authoring 53 peer reviewed articles and participating in 2 clinical trials. Dr. Bonagura is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
865 Northern Boulevard, Suite 101, Great Neck, NY 11021
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Clinical Pathology Associates
Paula Busse is an Allergy and Immunologist practicing medicine in New York,, New York. Dr. Busse is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Hereditary Angioedema, Angioedema, Hives, and Asthma.
CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
Joshua Milner is a leader in the field of discovery and immunopathogenesis of genetic diseases that lead to allergic symptoms. Among the disorders he has described and/or found major mechanistic insight are PLAID—an immune disorder that leads to lifelong cold urticaria, the glycosylation disorder PGM3 deficiency, ERBIN mutation, CARD11 dominant negative mutations, STAT3 gain-of-function, Hereditary Alpha Tryptasemia Syndrome, IL-6 receptor deficiency, and others. Dr. Milner graduated with an SB in biology from the Massachusetts Institute of Technology (MIT) in 1995 and an MD with distinction in immunology from the Albert Einstein College of Medicine. He completed his residency in pediatrics at the Children’s National Medical Center in Washington, DC, and, as the recipient of the Pediatric Scientist Development Program Fellowship, did his fellowship in allergy and immunology at NIAID. He completed a postdoctoral fellowship with Dr. William E. Paul, NIAID, examining issues of mouse T-cell receptor repertoires before beginning as an investigator in the Laboratory of Allergic Diseases in the NIAID, where he was eventually named chief.Dr. Milner's vision is to establish how genetic variation can help inform diagnosis and care of all patients with allergic disease—rare and common, severe and mild. This is achieved by performing genetic sequencing on samples from patients with allergic disease of all sorts, as well as performing functional studies on the same patient samples, which together help point to specific immune pathways that may be fundamentally causing disease. This comprehensive analysis, when performed in larger populations, will help personalize medicine so that patients can be better categorized for targeted care. Furthermore, this type of research and care requires a coordinated and comprehensive interdisciplinary approach, taking advantage of the expertise across the department of pediatrics and at multiple outpatient sites. Dr. Milner is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Hyper IgE Syndrome, Hyper IgE Syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), and Hereditary Alpha-Tryptasemia. Dr. Milner is board certified in Allergy And Immunology. Dr. Milner is currently accepting new patients.
CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
Dr. Ramsay Fuleihan is the clinical director of the Division of Pediatric Allergy, Immunology and Rheumatology and a professor of pediatrics at Columbia. Throughout his career his main research interest has been the pathogenesis and treatment of primary immunodeficiency diseases. Dr. Fuleihan was formerly chief of the division of allergy and immunology at Sidra Medical and Research Center in Qatar, and Director of Primary Immunodeficiency Clinical Services and the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at Ann & Robert H Lurie Children’s Hospital of Chicago. Dr. Fuleihan earned his medical degree from the American University of Beirut in Lebanon, completed his pediatric residency at Duke University Medical Center, and fellowship in allergy and immunology at the Children’s Hospital-Boston at Harvard Medical School. Dr. Fuleihan is a member of the Board of Directors of the American Board of Allergy and Immunology. He is an active fellow of the American Academy of Allergy Asthma and Immunology, where he served as Chair of the Primary Immunodeficiency Committee; a member of the Clinical Immunology Society, where he served as chair of the CME committee; a member of the European Society for Immunodeficiencies; and a member of the Society for Pediatric Research. He serves on the Medical Advisory Committee of the Immune Deficiency Foundation and on the Board of Directors of Bounce Children’s Foundation. Dr. Fuleihan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Common Variable Immune Deficiency, Primary Immunodeficiency (PID), Severe Combined Immunodeficiency (SCID), and X-Linked Agammaglobulinemia. Dr. Fuleihan is board certified in Pediatric Allergy And Immunology. Dr. Fuleihan is currently accepting new patients.
Frequently Asked Questions about Dr. Vincent R. Bonagura
How do I make an appointment with Dr. Vincent R. Bonagura?
You can book an appointment with Dr. Vincent R. Bonagura by calling their office at 516-622-5070. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Vincent R. Bonagura a top-rated expert for Primary Immunodeficiency (PID)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vincent R. Bonagura is classified as an Distinguished expert for Primary Immunodeficiency (PID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Vincent R. Bonagura specialize in?
While Dr. Vincent R. Bonagura is a Allergy and Immunology, they have specific expertise in Primary Immunodeficiency (PID), Immunodeficiency with Hyper IgM Type 1, and DiGeorge Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Allergy and Immunology.
Does Dr. Vincent R. Bonagura participate in research or clinical trials?
Yes. Dr. Vincent R. Bonagura has published 53 articles and abstracts on conditions like Primary Immunodeficiency (PID). You can view a list of Dr. Vincent R. Bonagura's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Vincent R. Bonagura accept my insurance?
Dr. Vincent R. Bonagura accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 516-622-5070 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Primary Immunodeficiency (PID)Dr. Bonagura isDistinguished. Learn about Primary Immunodeficiency (PID).
- Advanced
- DiGeorge SyndromeDr. Bonagura isAdvanced. Learn about DiGeorge Syndrome.
- Immunodeficiency with Hyper IgM Type 1
- Secondary Immunodeficiency (SID)Dr. Bonagura isAdvanced. Learn about Secondary Immunodeficiency (SID).
- Selective Deficiency of IgADr. Bonagura isAdvanced. Learn about Selective Deficiency of IgA.
- Experienced
- Allergic RhinitisDr. Bonagura isExperienced. Learn about Allergic Rhinitis.
- AsthmaDr. Bonagura isExperienced. Learn about Asthma.
- Common Variable Immune DeficiencyDr. Bonagura isExperienced. Learn about Common Variable Immune Deficiency.
- Complement Component 2 DeficiencyDr. Bonagura isExperienced. Learn about Complement Component 2 Deficiency.
- Febrile NeutropeniaDr. Bonagura isExperienced. Learn about Febrile Neutropenia.
- Hereditary AngioedemaDr. Bonagura isExperienced. Learn about Hereditary Angioedema.
- Hyperphenylalaninemia Due to Dehydratase Deficiency
- Infantile NeutropeniaDr. Bonagura isExperienced. Learn about Infantile Neutropenia.
- Omenn SyndromeDr. Bonagura isExperienced. Learn about Omenn Syndrome.
- Severe Combined Immunodeficiency (SCID)Dr. Bonagura isExperienced. Learn about Severe Combined Immunodeficiency (SCID).
- SinusitisDr. Bonagura isExperienced. Learn about Sinusitis.
- X-Linked Severe Combined ImmunodeficiencyDr. Bonagura isExperienced. Learn about X-Linked Severe Combined Immunodeficiency.


